BioSpace News Archive

Drug Development

ATTR Study Results Baffle BridgeBio

BridgeBio Pharma reported topline data from Part A (Month 12) of its Phase III study of acoramidis for symptomatic transthyretin amyloid cardiomyopathy. The drug failed the study arm.

December 28, 2021
·
3 min read
·
Mark Terry
Drug Development

Disappointing Phase III for Kiniksa’s COVID-19 Antibody

The company was assessing mavrilimumab as a potential therapeutic for COVID-19-related acute respiratory syndrome.

December 28, 2021
·
2 min read
·
Alex Keown
Drug Development

FDA Approves New Skin-Clearing Drug for Atopic Dermatitis

The decision to allow the release of Adbry follows positive results from the Phase III ECZTRA trials, which covered almost 2,000 patients living with moderate to severe atopic dermatitis.

December 28, 2021
·
2 min read
·
Vanessa Doctor, RN
Policy

Collegium Pharma Reaches Widespread Opioid Settlement

Collegium reached a $2.75 million agreement with a law firm representing 27 U.S. cities, counties and subdivisions related to the opioid crisis and the company’s sale of Xtampza.

December 28, 2021
·
2 min read
·
Alex Keown
FDA

LEO Pharma announces FDA approval of Adbry™ (tralokinumab-ldrm) as the first and only treatment specifically targeting IL-13 for adults with moderate-to-severe atopic dermatitis

LEO Pharma Inc. announced that the U.S. Food and Drug Administration has approved Adbry™ for the treatment of moderate-to-severe atopic dermatitis in adults 18 years or older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

December 28, 2021
·
11 min read
Drug Development

Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS

Kiniksa Pharmaceuticals, Ltd. today announced that the Phase 3 portion of the Phase 2/3 trial of mavrilimumab in COVID-19-related acute respiratory syndrome (ARDS) did not meet the primary efficacy endpoint.

December 28, 2021
·
9 min read
BioCapital

2020 Global Survey from ISAPS Sees Significant Changes in Aesthetic Procedures During Pandemic

The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, which showcased the impact of the COVID-19 pandemic on aesthetic plastic surgery procedures.

December 28, 2021
·
4 min read
Bio NC

Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference via webcast on Wednesday, January 12, 2022, at 5:15 p.m. ET.

December 28, 2021
·
1 min read
Lone Star Bio

Castle Biosciences to Present at the 24th Annual Needham Growth Conference

Castle Biosciences, Inc. today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the 24th Annual Needham Growth Conference on Monday, Jan. 10, 2022, at 12:30 p.m. Eastern time.

December 28, 2021
·
1 min read
Drug Development

Palatin Announces Initiation of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease

Palatin Technologies, Inc. announced the initiation of the pivotal Phase 3 MELODY-1 clinical study of PL9643 in patients with dry eye disease.

December 28, 2021
·
5 min read